Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 83161

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 14, 2019
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Golden State Medical Supply Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30

D-1462-2019
Recall number
D-1462-2019
Initiated
June 14, 2019
Classification
Class II
Status
Terminated
Quantity
4,037 bottles (121,110 tablets)

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA
Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Code information

Lot #: GS017479, Expiration 01/2020

Distribution pattern

US Nationwide One (1) US government account. No foreign accounts.

drug · product 2 of 4

Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90

D-1463-2019
Recall number
D-1463-2019
Initiated
June 14, 2019
Classification
Class II
Status
Terminated
Quantity
14,955 bottles (1,345,950 tablets)

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA
Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Code information

Lot #: GS017651, Expiration 01/2020

Distribution pattern

US Nationwide One (1) US government account. No foreign accounts.

drug · product 3 of 4

Losartan Potassium, 50 mg tablets, 1000 count bottle, NDC 60429-317-10

D-1464-2019
Recall number
D-1464-2019
Initiated
June 14, 2019
Classification
Class II
Status
Terminated
Quantity
1,470 bottles (1,470,000 tablets)

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA
Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Code information

Lot #: GS017387, Expiration 01/2020

Distribution pattern

US Nationwide One (1) US government account. No foreign accounts.

drug · product 4 of 4

Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90

D-1465-2019
Recall number
D-1465-2019
Initiated
June 14, 2019
Classification
Class II
Status
Terminated
Quantity
32,835 bottles (2,955,150 tablets)

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA
Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Code information

Lot #: GS017042, Expiration 01/2020; GS017043, Expiration 01/2020; GS017044, Expiration 01/2020; GS017541, Expiration 01/2020

Distribution pattern

US Nationwide One (1) US government account. No foreign accounts.